Moreover, it was reported that inhibition of Cdk5 activity enhanced CaMKII autophosphorylation/activation in cultured neurons [72], which suggests that Cdk5 inhibitors can be considered as potential drugs in the treatment of PD symptoms. This evidence concerns the gene CDK5 and Parkinson disease.